Gts Securities »

Cytokinetics shares owned by Gts Securities

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $27M 390k 70.11
2023-12-31 $90M 1.1M 83.49
2023-09-30 $990k 34k 29.46

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Broadcom Put Option (AVGO)
Advanced Micro Devices Put Option (AMD)
Microstrategy Cl A New Put Option (MSTR)

View all positions for Gts Securities

Top funds holding Cytokinetics

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Bank of America Corporation
T. Rowe Price Associates
Armistice Capital
Geode Capital Management
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Alliancebernstein
Marshall Wace
Partner Fund Management

View all funds holding Cytokinetics